Pediatric sinonasal neuroendocrine carcinoma after treatment of retinoblastoma

Human Pathology

Volumn 40, Issue 5, 2009, Pages 750-755

  Franchi, Alessandro ^a   Sardi, Iacopo ^a   Cetica, Valentina ^a   Buccoliero, Annamaria ^a   Giordano, Flavio ^b   Mussa, Federico ^b   Genitori, Lorenzo ^b   Oliveri, Giuseppe ^c   Miracco, Clelia ^d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

Author keywords

Nasal cavity; Neuroendocrine carcinoma; Retinoblastoma

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ARGININE; PROLINE; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER RECURRENCE; CASE REPORT; CELL PROLIFERATION; CHILD; CLINICAL FEATURE; DIAGNOSTIC IMAGING; EXON; FEMALE; GENE; HEADACHE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MISSENSE MUTATION; NEUROENDOCRINE TUMOR; NOSE CARCINOMA; PARESTHESIA; PRESCHOOL CHILD; RETINOBLASTOMA; SINGLE NUCLEOTIDE POLYMORPHISM; SINONASAL NEUROENDOCRINE CARCINOMA; SINUSITIS; SPHENOETHMOIDAL SINUSITIS; TP53 GENE; VOMITING;

ADOLESCENT; BASE SEQUENCE; CARCINOMA, NEUROENDOCRINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MUTATION, MISSENSE; NEOPLASMS, SECOND PRIMARY; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINAL NEOPLASMS; RETINOBLASTOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 64049084082     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.09.018     Document Type: Article

References (22)

1. Fletcher O., Easton D., Anderson K., Gilham C., Jay M., and Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96 (2004) 357-363
2. Kleinerman R.A., Tucker M.A., Tarone R.E., et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23 (2005) 2272-2279
3. Acquaviva A., Ciccolallo L., Rondelli R., et al. Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registry. Oncogene (2006) 5350-5357
4. Frierson Jr. H.F., Ross G.W., Stewart F.M., Newman S.A., and Kelly M.D. Unusual sinonasal small-cell neoplasms following radiotherapy for bilateral retinoblastomas. Am J Surg Pathol 13 (1989) 947-954
5. Greger V., Schirmacher P., Bohl J., et al. Possible involvement of the retinoblastoma gene in undifferentiated sinonasal carcinoma. Cancer 66 (1990) 1954-1959
6. Saw D., Chan J.K., Jagirdar J., Greco M.A., and Lee M. Sinonasal small cell neoplasm developing after radiation therapy for retinoblastoma: an immunohistologic, ultrastructural, and cytogenetic study. Hum Pathol 23 (1992) 896-899
7. Klein E.A., Anzil A.P., Mezzacappa P., Borderon M., and Ho V. Sinonasal primitive neuroectodermal tumor arising in a long-term survivor of heritable unilateral retinoblastoma. Cancer 70 (1992) 423-431
8. Ceha H.M., Balm A.J., de Jong D., and van't Veer L.J. Multiple malignancies in a patient with bilateral retinoblastoma. J Laryngol Otol 112 (1998) 189-192
9. Rowe L.D., Lane R., and Snow Jr. J.B. Adenocarcinoma of the ethmoid following radiotherapy for bilateral retinoblastoma. Laryngoscope 90 (1980) 61-69
10. Cope J.U., Tsokos M., and Miller R.W. Ewing sarcoma and sinonasal neuroectodermal tumors as second malignant tumors after retinoblastoma and other neoplasms. Med Pediatr Oncol 36 (2001) 290-294
11. Mills S.E. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 15 (2002) 264-278
12. Perez-Ordonez B. Neuroendocrine tumours. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). WHO classification of tumours. Pathology and genetics of head and neck tumours (2005), IARC Press, Lyon 26-27
13. Cerilli L.A., Holst V.A., Brandwein M.S., Stoler M.H., and Mills S.E. Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol 25 (2001) 156-163
14. Rapidis A.D., Economidis J., Goumas P.D., et al. Tumours of the head and neck in children. A clinico-pathological analysis of 1,007 cases. J Craniomaxillofac Surg 16 (1988) 279-286
15. Rahbar R., Vargas S.O., Miyamoto C.R., et al. Upper respiratory tract carcinoma with chromosomal translocation 15;19: evidence for a distinct disease entity of young patients with a rapidly fatal course. Cancer 92 (2001) 1195-1203
16. Soulitzis N., Sourvinos G., Dokianakis D.N., and Spandidos D.A. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 179 (2002) 175-183
17. Boltze C., Roessner A., Landt O., Szibor R., Peters B., and Schneider-Stock R. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma. Int J Oncol 2 (2002) 1151-1154
18. Hamel N., Black M.J., Ghadirian P., and Foulkes W.D. No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer 82 (2000) 757-759
19. McWilliams J.E., Evans A.J., Beer T.M., et al. Genetic polymorphisms in head and neck cancer risk. Head Neck 22 (2000) 609-617
20. Yarbrough W.G., Aprelikova O., Pei H., Olshan A.F., and Liu E.T. Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst 88 (1996) 1489-1491
21. Chen C.L., and Hsu M.M. Second primary epithelial malignancy of nasopharynx and nasal cavity after successful curative radiation therapy of nasopharyngeal carcinoma. Hum Pathol 31 (2000) 227-232
22. Wang C.P., Hsieh C.Y., Chang Y.L., et al. Postirradiated neuroendocrine carcinoma of the sinonasal tract. Laryngoscope 118 (2008) 804-809